Blog
RSS FeedPosted by Michael Wonder on 27 Jan 2017
Recommendations made by the PBAC - December 2016
27 January 2016 - The outcomes from the December 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 26 Jan 2017
Final yes from NICE for Gilead’s Epclusa
26 January 2017 - NICE has now published final guidance endorsing Epclusa as an option for the treatment of adults ...
Posted by Michael Wonder on 26 Jan 2017
Approval of proposal for clostridium botulinum type A toxin (Botox) in DHB hospitals
26 January 2017 - PHARMAC is pleased to announce the approval of an agreement with Allergan to amend the contractual ...
Posted by Michael Wonder on 25 Jan 2017
NICE guidance on ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia in the presence of 17p deletion or TP53 mutation
25 January 2017 - NICE published guidance that recommended ibrutinib for chronic lymphocytic leukaemia in adults who have had at ...
Posted by Michael Wonder on 25 Jan 2017
Bupa warns health insurers face unsustainable cost increases
26 January 2017 - Bupa has warned the Turnbull government that affordability concerns have driven the private health insurance sector ...
Posted by Michael Wonder on 25 Jan 2017
Woman plans to sell home to pay for pancreatic cancer treatment
24 January 2017 - A woman has been forced to sell her paintings, jewellery and now even her house after ...
Posted by Michael Wonder on 23 Jan 2017
UK pharma slams new drug evaluation plans
23 January 2017 - ABPI and BIA oppose "arbitrary" proposal to impose £100,000 QALY limit on rare disease therapies. ...
Posted by Michael Wonder on 23 Jan 2017
NICE seeks positive future with life sciences industry
20 January 2017 - NICE has set out its position on its complex but positive relationship with the life sciences industry. ...
Posted by Michael Wonder on 23 Jan 2017
Indicative 1 April 2017 prices - 2017 April cycle
23 January 2017 - Indicative 1 April 2017 prices resulting from the 2017 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 22 Jan 2017
Specialists’ fees drive up out-of-pocket costs for patients
23 January 2017 - Australian patients are increasingly being forced to pay higher out-of-pocket costs for common procedures, with some ...
Posted by Michael Wonder on 22 Jan 2017
Medicare levy increase on the table as Turnbull budget speculation begins
22 January 2017 - Doctors believe the Turnbull government could be contemplating another increase in the Medicare levy. ...
Posted by Michael Wonder on 22 Jan 2017
In Brad Wall’s deal, clues for Medicare’s future
20 January 2017 - Provinces holding out from signing a health-care accord with the federal government were dealt a significant ...
Posted by Michael Wonder on 22 Jan 2017
Cystic fibrosis sufferer Scarlet Fox 1 million dollars away from access to life-changing drug Kalydeco
21 January 2017 - As a two-year-old living with cystic fibrosis, Scarlet Fox is $1 million away from access to ...
Posted by Michael Wonder on 22 Jan 2017
Call for feedback on a therapeutic review update of new second-line therapies for type 2 diabetes mellitus
20 January 2017 - Two draft science reports on new drugs for type 2 diabetes: second-line therapy : a therapeutic review ...
Posted by Michael Wonder on 19 Jan 2017
CADTH style guide
19 January 2017 - This fifth edition of the CADTH Style Guide provides the most current style and language usage ...